Importantly, fibrinogen consistently associated with biomarkers of tauopathy but not amyloidopathy across all cohorts investigated, suggesting a direct link between CNS thromboinflammation, brain barrier dysfunction, and tau-related neurodegeneration. This evidence concerns the gene MAPT and tauopathy.